{"id":"https://openalex.org/W7224136551","doi":"https://doi.org/10.1080/10428194.2026.2735668","title":"Zanubrutinib with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory non\u2013germinal center B-cell lymphoma","display_name":"Zanubrutinib with rituximab, ifosfamide, carboplatin, and etoposide for relapsed or refractory non\u2013germinal center B-cell lymphoma","publication_year":2026,"publication_date":"2026-10-28","ids":{"openalex":"https://openalex.org/W7224136551","doi":"https://doi.org/10.1080/10428194.2026.2735668","pmid":"https://pubmed.ncbi.nlm.nih.gov/42950107"},"language":"en","primary_location":{"id":"doi:10.1080/10428194.2026.2735668","doi":"https://doi.org/10.1080/10428194.2026.2735668","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2026.2735668","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5015998433","display_name":"Wei Chen","orcid":"https://orcid.org/0000-0001-6886-9923","observed_orcids":["https://orcid.org/0000-0001-6886-9923"]},"institutions":[{"id":"https://openalex.org/I4210156545","display_name":"Dongyang People's Hospital","ror":"https://ror.org/04fszpp16","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210156545"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Wei Chen","raw_affiliation_strings":["Dongyang People\u2019s Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dongyang People\u2019s Hospital","institution_ids":["https://openalex.org/I4210156545"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5089289098","display_name":"Fang Yuan","orcid":"https://orcid.org/0000-0002-1144-434X","observed_orcids":["https://orcid.org/0000-0002-1144-434X"]},"institutions":[{"id":"https://openalex.org/I4210158318","display_name":"Second Affiliated Hospital of Zhejiang University","ror":"https://ror.org/059cjpv64","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210158318"]},{"id":"https://openalex.org/I76130692","display_name":"Zhejiang University","ror":"https://ror.org/00a2xv884","country_code":"CN","type":"education","lineage":["https://openalex.org/I76130692"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Fang Yuan","raw_affiliation_strings":["Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, National Ministry of Education), Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cancer Institute (Key Laboratory of Cancer Prevention and Intervention, National Ministry of Education), Second Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang University","institution_ids":["https://openalex.org/I4210158318","https://openalex.org/I76130692"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160040454","display_name":"Jieyu Xu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Jieyu Xu","raw_affiliation_strings":["Department of Lymphoma, Zhejiang Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma, Zhejiang Cancer Hospital","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102457342","display_name":"Shuailing Peng","orcid":"https://orcid.org/0009-0006-1535-7338","observed_orcids":["https://orcid.org/0009-0006-1535-7338"]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuailing Peng","raw_affiliation_strings":["Department of Lymphoma, Zhejiang Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma, Zhejiang Cancer Hospital","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160051310","display_name":"Xi Chen","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Xi Chen","raw_affiliation_strings":["Department of Lymphoma, Zhejiang Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma, Zhejiang Cancer Hospital","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5160031440","display_name":"Shuiyun Han","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":false,"raw_author_name":"Shuiyun Han","raw_affiliation_strings":["Department of Lymphoma, Zhejiang Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma, Zhejiang Cancer Hospital","institution_ids":["https://openalex.org/I4210098734"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5160009231","display_name":"Haifeng Yu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210098734","display_name":"Zhejiang Cancer Hospital","ror":"https://ror.org/0144s0951","country_code":"CN","type":"healthcare","lineage":["https://openalex.org/I4210098734"]}],"countries":["CN"],"is_corresponding":true,"raw_author_name":"Haifeng Yu","raw_affiliation_strings":["Department of Lymphoma, Zhejiang Cancer Hospital"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Lymphoma, Zhejiang Cancer Hospital","institution_ids":["https://openalex.org/I4210098734"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5160009231"],"corresponding_institution_ids":["https://openalex.org/I4210098734"],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.84738692,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"1","last_page":"8"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9556000232696533,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.041600000113248825,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12212","display_name":"CNS Lymphoma Diagnosis and Treatment","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/zanubrutinib","display_name":"zanubrutinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/rituximab","display_name":"rituximab","score":0.8569999933242798},{"id":"https://openalex.org/keywords/ifosfamide","display_name":"ifosfamide","score":0.9950000047683716},{"id":"https://openalex.org/keywords/carboplatin","display_name":"carboplatin","score":1.0},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-lymphoma","display_name":"relapsed/refractory lymphoma","score":0.9300000071525574},{"id":"https://openalex.org/keywords/bruton-tyrosine-kinase-inhibitors","display_name":"BTK inhibitors","score":0.8659999966621399},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.6830000281333923}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7200000286102295},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.5530999898910522},{"id":"https://openalex.org/C2778119113","wikidata":"https://www.wikidata.org/wiki/Q418817","display_name":"Etoposide","level":3,"score":0.4912000000476837},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.46059998869895935},{"id":"https://openalex.org/C2779463800","wikidata":"https://www.wikidata.org/wiki/Q5062222","display_name":"Center (category theory)","level":2,"score":0.4429999887943268},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.44200000166893005},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4359999895095825},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4162999987602234},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3343000113964081},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.2773999869823456},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.2669000029563904},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.25450000166893005},{"id":"https://openalex.org/C2778559949","wikidata":"https://www.wikidata.org/wiki/Q2626074","display_name":"Diffuse large B-cell lymphoma","level":3,"score":0.25270000100135803},{"id":"https://openalex.org/C2777295375","wikidata":"https://www.wikidata.org/wiki/Q609503","display_name":"Gliosarcoma","level":3,"score":0.2502000033855438}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1080/10428194.2026.2735668","doi":"https://doi.org/10.1080/10428194.2026.2735668","is_oa":false,"landing_page_url":"https://doi.org/10.1080/10428194.2026.2735668","pdf_url":null,"source":{"id":"https://openalex.org/S27064115","display_name":"Leukemia & lymphoma/Leukemia and lymphoma","issn_l":"1026-8022","issn":["1026-8022","1029-2403","1042-8194"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320547","host_organization_name":"Taylor & Francis","host_organization_lineage":["https://openalex.org/P4310320547","https://openalex.org/P4310320449"],"host_organization_lineage_names":["Taylor & Francis","Informa"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & Lymphoma","raw_type":"journal-article"},{"id":"pmid:42950107","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/42950107","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Leukemia & lymphoma","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":33,"referenced_works":["https://openalex.org/W1020989877","https://openalex.org/W1799746163","https://openalex.org/W1974866935","https://openalex.org/W1997353354","https://openalex.org/W2018071905","https://openalex.org/W2038023916","https://openalex.org/W2096301685","https://openalex.org/W2111716055","https://openalex.org/W2119147717","https://openalex.org/W2120415962","https://openalex.org/W2133345449","https://openalex.org/W2134168335","https://openalex.org/W2140485109","https://openalex.org/W2143166224","https://openalex.org/W2150587745","https://openalex.org/W2153665789","https://openalex.org/W2160848167","https://openalex.org/W2518731208","https://openalex.org/W2737051529","https://openalex.org/W2744261860","https://openalex.org/W2786522183","https://openalex.org/W2807205254","https://openalex.org/W2979348411","https://openalex.org/W3134205746","https://openalex.org/W3207071979","https://openalex.org/W4200139163","https://openalex.org/W4210794959","https://openalex.org/W4214859401","https://openalex.org/W4308964141","https://openalex.org/W4309842506","https://openalex.org/W4392698975","https://openalex.org/W4393994911","https://openalex.org/W4398208127"],"related_works":["https://openalex.org/W3207071979","https://openalex.org/W3028712600","https://openalex.org/W4312093980","https://openalex.org/W6947781158","https://openalex.org/W4413790783","https://openalex.org/W4367834276","https://openalex.org/W4413791591","https://openalex.org/W7151471598","https://openalex.org/W7135168355","https://openalex.org/W4413791746"],"abstract_inverted_index":{"To":[0],"evaluate":[1],"the":[2,69,75,91,105,114,156],"effectiveness":[3],"and":[4,12,74,82,90,121,124,139],"safety":[5,154],"of":[6,32,54,66,100,158],"zanubrutinib":[7,44],"plus":[8],"rituximab,":[9],"ifosfamide,":[10],"carboplatin,":[11],"etoposide":[13],"(ZRICE)":[14],"in":[15,155],"patients":[16],"with":[17,38,152],"relapsed":[18],"or":[19],"refractory":[20],"(R/R),":[21],"non-germinal":[22],"center":[23],"B-cell-like":[24],"diffuse":[25],"large":[26],"B-cell":[27],"lymphoma":[28],"(DLBCL).":[29],"Retrospective":[30],"study":[31],"20":[33],"adults":[34],"(median":[35,59],"age":[36],"54.4)":[37],"R/R":[39,159],"DLBCL":[40],"receiving":[41],"second-line":[42],"ZRICE;":[43],"160":[45],"mg":[46],"twice":[47],"daily":[48],"for":[49],"\u22646":[50],"cycles.":[51],"A":[52],"total":[53],"72":[55],"cycles":[56,65],"were":[57,80,126],"administered":[58],"4":[60],"per":[61],"patient).":[62],"After":[63],"2":[64],"ZRICE":[67,146],"treatment,":[68],"overall":[70,115],"response":[71,77,151],"rate":[72,93,110,118],"(ORR)":[73],"complete":[76],"(CR)":[78],"rates":[79],"90.0%":[81],"70.0%,":[83],"respectively.":[84],"The":[85],"best":[86],"ORR":[87],"was":[88,94,111,119],"90.0%,":[89],"CR":[92],"80.0%.":[95],"At":[96],"a":[97,143,148],"median":[98,122],"follow-up":[99],"30.5":[101],"(range,":[102],"5-58)":[103],"months,":[104],"2-year":[106],"progression-free":[107],"survival":[108,116],"(PFS)":[109],"69.3%,":[112],"whereas":[113],"(OS)":[117],"75.0%,":[120],"PFS":[123],"OS":[125],"not":[127],"reached.":[128],"Common":[129],"grades":[130],"\u22654":[131],"hematologic":[132],"adverse":[133],"events":[134],"(AEs)":[135],"included":[136],"anemia":[137],"(50.0%)":[138],"neutropenia":[140],"(75.0%).":[141],"In":[142],"real-world":[144],"setting,":[145],"showed":[147],"durable":[149],"clinical":[150],"tolerable":[153],"treatment":[157],"DLBCL.":[160]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2026-10-29T00:00:00"}